European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
EMA validates Type II variation application for Padcev with Keytruda for first line treatment of advanced Bladder Cancer: Pfizer Ruchika Sharma28 Jan 2024 10:00 AM ISTTokyo: Astellas Pharma Inc. and Pfizer Inc. have announced that the European Medicines Agency (EMA) has validated for review a Type II...
Merck bags USFDA nod for Keytruda, Padcev combo for urothelial cancer Ruchika Sharma18 Dec 2023 1:45 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
Immunotherapy after surgery is beneficial for high-risk bladder cancer patients Dr. Kamal Kant Kohli4 April 2023 10:00 AM ISTUSA: Immunotherapy after surgery increases the chance of staying cancer-free in bladder cancer patients compared to those who received a placebo,...
Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer Ruchika Sharma22 Dec 2022 3:21 PM ISTPADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface...
First Mutation-Targeted Bladder Cancer Drug May Be Under-Used Dr. Kamal Kant Kohli19 May 2022 8:00 PM IST PHILADELPHIA: The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Sacituzumab govitecan, promising treatment option for advanced urothelial cancer: Phase 2 trial Hina Zahid7 Aug 2021 9:00 AM ISTUSA: A new treatment called sacituzumab govitecan (SG) is effective with tolerable side effects in patients with advanced urothelial cancer, show...
Enfortumab vedotin-ejfv receives FDA approval and expanded indication for urothelial cancer Medha Baranwal14 July 2021 12:00 AM ISTUSA: Padcev (enfortumab vedotin-ejfv) has received the FDA's (Food and Drug Administration) regular approval for the treatment of adults with locally...
Postoperative immunotherapy reduces risk of bladder cancer recurrence: Study Hina Zahid5 Jun 2021 9:39 AM ISTThese findings have the potential to change the standard of care for bladder cancer. Patients who received adjuvant nivolumab (Opdivo) following...
Gilead Sciences cancer drug Trodelvy gets speedy USFDA approval Ruchika Sharma14 April 2021 4:11 PM ISTFoster City: Drugmaker, Gilead Sciences, has recently announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated...
PPI use in Urothelial Cancer linked to higher mortality, finds study Dr Satabdi Saha29 Sept 2020 3:53 PM ISTThe study published in Clinical Cancer Research, suggested in a retrospective analysis of clinical trials investigating the immune checkpoint...
